Asia Pacific Anesthesia Drugs Market by Drug Types (General Anesthesia Drugs [Propofol, Sevoflurane, Isoflurane, Dexmedetomidine, Remifentanil, Desflurane, Midazolam, and Others], Local Anesthesia Drugs [Lidocaine, Ropivacaine, Chloroprocaine, Articaine, Benzocaine, Bupivacaine, and Others ]), Route of Administrations (Injection, Inhalation, and Others), Applications (General Surgery, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, and Others), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.
The Asia Pacific anesthesia drugs market size is anticipated to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing awareness about the safe surgical procedures.
An anesthetic is a painkiller used during surgery. Many pieces of equipment, such as anesthetic vaporizers and nasal oxygen sets are specifically built for certain surgical procedures. Almost all surgical procedures today require anesthesia. Anesthesia functions by preventing nerve signals from reaching the brain and keeping the patient awake. Procedures can be performed without the patient experiencing anything during this stage of induced sleep. Nerve signals are able to reach the brain once the anesthesia wears off.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing prevalence of chronic diseases and surgical procedure such as bypass surgery and pain control is anticipated to drive market growth.
- Decreasing efficacy of current drugs can hamper the market expansion.
- Favorable reimbursement policies can positively influence the market growth in the projected timeline.
- Expanding investment in R&D for developing novel and efficient drugs are creating ample opportunities for the anesthesia drugs market.
Scope of the Report
The report on the Asia Pacific anesthesia drugs market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Anesthesia Drugs Market - Asia-Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Drug Types (General Anesthesia Drugs[Propofol, Sevoflurane, Isoflurane, Dexmedetomidine, Remifentanil, Desflurane, Midazolam, and Others], Local Anesthesia Drugs [Lidocaine, Ropivacaine, Chloroprocaine, Articaine, Benzocaine , Bupivacaine, and Others]), Route of Administrations (Injection, Inhalation, and Others), Applications (General Surgery, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, and Others) |
| Geographical scope | China, Japan, India, Australia, South Korea, and Rest of Asia Pacific |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Aspen Holdings; Baxter International; AbbVie Inc; Fresenius SE & Co. KGaA; and B. Braun Melsungen AG |
Asia-Pacific Anesthesia Drugs Market Segment Insights
Local anesthesia drugs segment is expected to grow at a rapid pace
Based on drugs types, the market is divided into general anesthesia drugs, and local anesthesia drugs. The general anesthesia drugs segment is classified as propofol, sevoflurane, isoflurane, dexmedetomidine, remifentanil, desflurane, midazolam, and others. The local anesthesia drugs segment is further categorized as lidocaine, ropivacaine, chloroprocaine, articaine, benzocaine, bupivacaine, and others. The local anesthesia drugs segment is expected to grow at a rapid pace during the forecast period owing to increasing number of accidents and surgeries.
Injection segment is projected to expand at a considerable CAGR
On the basis of route of administrations, the market is segregated into injection, inhalation, and others. The injection segment is projected to expand at a considerable CAGR during the forecast period due to technological advancements in drug delivery devices. Rising number of surgeries is propelling the segment growth.
Cosmetic surgeries segment is anticipated to account for a significant market share.
Based on applications, the market is divided into general surgery, plastic surgery, cosmetic surgeries, dental surgeries, and others. The cosmetic surgeries segment is estimated to account for a significant market share during the forecast period owing to rapid development of patient monitoring equipment and specially targeted medications.
Japan is anticipated to constitute a key market share
In terms of geography, the Asia Pacific anesthesia drugs market is categorized China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Japan is expected to constitute a key share of the market during the projected period due to early technological adoption and highly specialized healthcare infrastructure. On the other hand, the market in India is expected to grow at a rapid pace during the forecast period.
Segments
Segments Covered in the Report
The Asia Pacific anesthesia drugs market has been segmented on the basis of
Drug Types
- General Anesthesia Drugs
- Propofol
- Sevoflurane
- Isoflurane
- Dexmedetomidine
- Remifentanil
- Desflurane
- Midazolam
- Others
- Local Anesthesia Drugs
- Lidocaine
- Ropivacaine
- Chloroprocaine
- Articaine
- Benzocaine
- Bupivacaine
- Others
Route of Administrations
- Injection
- Inhalation
- Others
Applications
- General Surgery
- Plastic Surgery
- Cosmetic Surgeries
- Dental Surgeries
- Others
Geography
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Key Players
- Aspen Holdings
- Baxter International
- AbbVie Inc
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
Competitive Landscape
Key players competing in the Asia Pacific anesthesia drugs market are Aspen Holdings; Baxter International; AbbVie Inc; Fresenius SE & Co. KGaA; and B. Braun Melsungen AG.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Anesthesia Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Anesthesia Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Anesthesia Drugs Market - Supply Chain
4.5. Global Anesthesia Drugs Market Forecast
4.5.1. Anesthesia Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Anesthesia Drugs Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Anesthesia Drugs Market Absolute $ Opportunity
5. Global Anesthesia Drugs Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Anesthesia Drugs Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Anesthesia Drugs Demand Share Forecast, 2019-2026
6. North America Anesthesia Drugs Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Anesthesia Drugs Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Anesthesia Drugs Demand Share Forecast, 2019-2026
7. Latin America Anesthesia Drugs Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Anesthesia Drugs Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Anesthesia Drugs Demand Share Forecast, 2019-2026
8. Europe Anesthesia Drugs Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Anesthesia Drugs Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Anesthesia Drugs Demand Share Forecast, 2019-2026
9. Asia Pacific Anesthesia Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Anesthesia Drugs Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Anesthesia Drugs Demand Share Forecast, 2019-2026
10. Middle East & Africa Anesthesia Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Anesthesia Drugs Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Anesthesia Drugs Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Anesthesia Drugs Market: Market Share Analysis
11.2. Anesthesia Drugs Distributors and Customers
11.3. Anesthesia Drugs Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Aspen Holdings
11.4.2. Baxter International
11.4.3. AbbVie Inc
11.4.4. Fresenius SE & Co. KGaA
11.4.5. B. Braun Melsungen AG
Segments Covered in the Report
The Asia Pacific anesthesia drugs market has been segmented on the basis of
Drug Types
- General Anesthesia Drugs
- Propofol
- Sevoflurane
- Isoflurane
- Dexmedetomidine
- Remifentanil
- Desflurane
- Midazolam
- Others
- Local Anesthesia Drugs
- Lidocaine
- Ropivacaine
- Chloroprocaine
- Articaine
- Benzocaine
- Bupivacaine
- Others
Route of Administrations
- Injection
- Inhalation
- Others
Applications
- General Surgery
- Plastic Surgery
- Cosmetic Surgeries
- Dental Surgeries
- Others
Geography
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Key Players
- Aspen Holdings
- Baxter International
- AbbVie Inc
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
Key players competing in the Asia Pacific anesthesia drugs market are Aspen Holdings; Baxter International; AbbVie Inc; Fresenius SE & Co. KGaA; and B. Braun Melsungen AG.
Our Clients
Related Reports
Some other reports from this category!
